235 related articles for article (PubMed ID: 28349245)
1. Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.
Kishida Y; Okubo H; Ohno H; Oki K; Yoneda M
J Gastroenterol; 2017 Nov; 52(11):1180-1191. PubMed ID: 28349245
[TBL] [Abstract][Full Text] [Related]
2. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model.
Okubo H; Nakatsu Y; Sakoda H; Kushiyama A; Fujishiro M; Fukushima T; Matsunaga Y; Ohno H; Yoneda M; Kamata H; Shinjo T; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G151-8. PubMed ID: 25428903
[TBL] [Abstract][Full Text] [Related]
3. Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway.
Lee EY; Zhang X; Miyamoto J; Kimura I; Taknaka T; Furusawa K; Jomori T; Fujimoto K; Uematsu S; Miki T
J Endocrinol; 2018 Dec; 239(3):267-276. PubMed ID: 30400014
[TBL] [Abstract][Full Text] [Related]
4. 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis.
Zheng J; Zhu L; Hu B; Zou X; Hu H; Zhang Z; Jiang N; Ma J; Yang H; Liu H
J Nutr Biochem; 2019 Sep; 71():16-26. PubMed ID: 31272028
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
Honda Y; Ozaki A; Iwaki M; Kobayashi T; Nogami A; Kessoku T; Ogawa Y; Tomeno W; Imajo K; Yoneda M; Saito S; Nagashima Y; Nakajima A
J Pharmacol Sci; 2021 Oct; 147(2):176-183. PubMed ID: 34384565
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice.
Cao Y; Pan Q; Cai W; Shen F; Chen GY; Xu LM; Fan JG
Arch Iran Med; 2016 Mar; 19(3):197-203. PubMed ID: 26923892
[TBL] [Abstract][Full Text] [Related]
8. Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.
Lee EY; Kaneko S; Jutabha P; Zhang X; Seino S; Jomori T; Anzai N; Miki T
J Endocrinol; 2015 Mar; 224(3):205-14. PubMed ID: 25486965
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
[TBL] [Abstract][Full Text] [Related]
10. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
Rubio C; Puerto M; García-Rodríquez JJ; Lu VB; García-Martínez I; Alén R; Sanmartín-Salinas P; Toledo-Lobo MV; Saiz J; Ruperez J; Barbas C; Menchén L; Gribble FM; Reimann F; Guijarro LG; Carrascosa JM; Valverde ÁM
Mol Metab; 2020 May; 35():100954. PubMed ID: 32244182
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
Dey P; Olmstead BD; Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
J Nutr Biochem; 2020 Oct; 84():108455. PubMed ID: 32688217
[TBL] [Abstract][Full Text] [Related]
12. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Hamada Y; Nagasaki H; Fuchigami M; Furuta S; Seino Y; Nakamura J; Oiso Y
Metabolism; 2013 May; 62(5):734-42. PubMed ID: 23194643
[TBL] [Abstract][Full Text] [Related]
13. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.
Okubo H; Sakoda H; Kushiyama A; Fujishiro M; Nakatsu Y; Fukushima T; Matsunaga Y; Kamata H; Asahara T; Yoshida Y; Chonan O; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G911-8. PubMed ID: 24113768
[TBL] [Abstract][Full Text] [Related]
15. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
[TBL] [Abstract][Full Text] [Related]
16. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.
Zhou D; Pan Q; Shen F; Cao HX; Ding WJ; Chen YW; Fan JG
Sci Rep; 2017 May; 7(1):1529. PubMed ID: 28484247
[TBL] [Abstract][Full Text] [Related]
17. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model.
Achiwa K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Katano Y; Goto H
Biochem Biophys Res Commun; 2016 Jan; 470(1):15-21. PubMed ID: 26682925
[TBL] [Abstract][Full Text] [Related]
18. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
Valdecantos MP; Pardo V; Ruiz L; Castro-Sánchez L; Lanzón B; Fernández-Millán E; García-Monzón C; Arroba AI; González-Rodríguez Á; Escrivá F; Álvarez C; Rupérez FJ; Barbas C; Konkar A; Naylor J; Hornigold D; Santos AD; Bednarek M; Grimsby J; Rondinone CM; Valverde ÁM
Hepatology; 2017 Mar; 65(3):950-968. PubMed ID: 27880981
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
20. Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human-Like Bile Acid Composition.
Iwamoto J; Honda A; Miyazaki T; Monma T; Ueda H; Morishita Y; Yara SI; Hirayama T; Ikegami T
Hepatol Commun; 2021 Dec; 5(12):2052-2067. PubMed ID: 34558859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
